Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results

COVID-19 mild to moderate meta-analysis

Fu, 2020
RCTinterferon / TFF2standard of careCOVID-19 mild to moderatesome concern
40/40 no results
    Idelsis, 2020
    RCTinterferoninterferonCOVID-19 mild to moderatehigh
    30/33 conclusif
    • demonstrated 2.3-fold increase in PCR-negative conversion (time to event analysis only) (PE) but with a low degree of certainty due to high risk of bias
    Khamis, 2020 RCTinterferonstandard of careCOVID-19 mild to moderatesome concern
    44/45 inconclusive

      PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
      Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).